Correlation of Venous Oxygen Saturations from Noninvasive Hematocrit Monitoring Using Blood Gas Measured Oximetry in Chronic Pediatric Hemodialysis Patients

2020 ◽  
Vol 49 (6) ◽  
pp. 665-669
Author(s):  
Alexandra Idrovo ◽  
Jessica Geer ◽  
Catharina H. Solomon ◽  
Sridevi Devaraj ◽  
Sarah J. Swartz ◽  
...  

<b><i>Introduction:</i></b> Noninvasive hematocrit monitoring (NIVHM) during pediatric hemodialysis (pedHD) provides data in real time regarding changes in hematocrit and blood volume and also provides venous oxygen saturations. The latter has been proposed to indicate changes in tissue oxygen consumption. It is not known how well NIVHM oxygen saturations (O2sat) approximate blood gas measured oximetry saturation (mO2sat) in the course of pedHD. We aimed to assess the validity and reliability of NIVHM O2sat compared to mO2sat. <b><i>Methods:</i></b> This is a prospective study in 15 patients &#x3c;21 years old with &#x3e;90 days on hemodialysis (HD) without congenital heart disease. HD access was fistula (AVF) in 4 patients and tunneled catheters in the remainder. Pulse oximetry (spO2) was continuously monitored; mO2sat was measured via oximetry in a blood gas analyzer and NIVHM O2sat values collected at the start, middle, and end of HD treatment. <b><i>Results:</i></b> A total of 45 dyad measurements were obtained. NIVHM O2sat correlated well with mO2sat (<i>R</i> = 0.89, <i>p</i> &#x3c; 0.0001); the same was seen at pre, mid, and post HD time points (<i>R</i> = 0.86–0.95, <i>p</i> &#x3c; 0.001). NIVHM O2sat was lower than mO2sat; with catheter as access, the difference was 9.3 ± 8.6 (CI: 12.3–6.22, <i>p</i> &#x3c; 0.0001) and with AVF was 2.1 ± 0.78 (CI: 2.6–1.7, <i>p</i> &#x3c; 0.0001). Bland-Altman analysis demonstrated the difference but did not show any systematic bias. Continuous monitor of spO2 showed no hypoxia. <b><i>Discussion/Conclusion:</i></b> Intradialytic NIVHM O2sat correlates well with mO2sat but yield lower values. Future studies can include NIVHM O2sat changes as a surrogate for central venous O2 saturation changes and potentially yield useful information regarding tissue oxygen consumption in pedHD patients.

Neurology ◽  
1997 ◽  
Vol 49 (3) ◽  
pp. 837-841 ◽  
Author(s):  
K. Abe ◽  
Y. Matsuo ◽  
J. Kadekawa ◽  
S. Inoue ◽  
T. Yanagihara

1983 ◽  
Vol 58 (4) ◽  
pp. 526-530 ◽  
Author(s):  
Nariyuki Hayashi ◽  
Barth A. Green ◽  
Mayra Gonzalez-Carvajal ◽  
Joseph Mora ◽  
Richard P. Veraa

✓ Using a reliable and reproducible microelectrode technique, consistent simultaneous measurements of local spinal cord blood flow (SCBF), tissue oxygen tension, and tissue oxygen consumption were made at cervical, thoracic, and lumbar levels in the rat spinal cord. These observations showed that the metabolic state is maintained constant along the cord, despite significant variations in vasculature. The physiological and anatomical aspects of these findings are discussed.


1991 ◽  
Vol 19 (4) ◽  
pp. 503-508 ◽  
Author(s):  
KRISTIINA HERSIO ◽  
JUKKA TAKALA ◽  
AARNO KARI MD ◽  
HEIKKI HUTTUNEN

1987 ◽  
pp. 87-97
Author(s):  
P. Conzen ◽  
J. Hobbhahn ◽  
A. Goetz ◽  
H. Habazettl ◽  
T. Granetzny ◽  
...  

1960 ◽  
Vol XXXIII (III) ◽  
pp. 406-410 ◽  
Author(s):  
K. Kowalewski ◽  
G. Bekesi

ABSTRACT The effect of the treatment of male rats with an anabolic androgen, 17-ethyl-19-nortestosterone, on the oxygen consumption and anaerobic glycolysis of some tissue slices was studied. Highly significant depression of the oxygen uptake of the diaphragm and liver slices was observed in animals treated with 17-ethyl-19-nortestosterone. This steroid had no significant effect on the anaerobic glycolysis of diaphragmatic slices in the rats.


Blood ◽  
1972 ◽  
Vol 40 (6) ◽  
pp. 905-913
Author(s):  
Charles W. Seward ◽  
John W. Eaton ◽  
Hugh Chaplin

Abstract Depression of thyroid function in patients with hemoglobin SS disease might be expected to: (1) reduce tissue oxygen consumption, (2) decrease erythrocyte 2, 3-diphosphoglycerate, (3) decrease p50, (4) increase the average level of erythrocyte oxygenation, and (5) increase in vivo red cell survival with associated improvement in anemia and possibly in musculoskeletal symptoms. Accordingly, 150-200 mg of 6-n-propylthiouracil were administered three times a day for 143 days to a 21-yr-old male with hemoglobin SS disease. Thyrosuppression was indicated by typical symptoms and appropriate changes in physical and biochemical parameters. Detailed hematologic follow-up, including multiple measurements of red cell mass, 51Cr erythrocyte survival, red cell 2,3-diphosphoglycerate, and p50, showed no change. Furthermore, musculoskeletal symptoms continued in the pattern characteristic of the euthyroid state. A possible explanation for the lack of any change in clinical status may be that decreased cardiac output, with attendant prolonged circulation time and increased tissue oxygen demand per red cell per unit time, offset the absolute decrease in tissue oxygen consumption. The study provided an opportunity to make detailed clinical observations of sickle cell disease in association with thyroid suppression. The results suggest that thyrosuppression within the limits of symptomatic and physiologic tolerance has no therapeutic application in the clinical management of hemoglobin SS disease.


Sign in / Sign up

Export Citation Format

Share Document